Assessment of Hepatic Fibrosis by Shear Wave Elastography in Patients With Liver Malignancy: A Prospective Single-center Study
1 other identifier
observational
121
0 countries
N/A
Brief Summary
To evaluate the diagnostic performance of two-dimensional shear-wave elastography (SWE) for staging hepatic fibrosis in the background liver parenchyma in patients with liver tumors before hepatic resection, using resected tissue pathology as a reference standard.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2015
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2016
CompletedFirst Submitted
Initial submission to the registry
November 5, 2016
CompletedFirst Posted
Study publicly available on registry
November 8, 2016
CompletedNovember 8, 2016
November 1, 2016
9 months
November 5, 2016
November 5, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Stage of hepatic fibrosis
compare the stage of hepatic fibrosis between SWE test with specimens after surgery
within the first 7 days after surgery
Study Arms (1)
study group
patients with liver tumor intend to perform hepatectomy
Interventions
performa two-dimensional shear-wave elastography (SWE) for staging hepatic fibrosis in the background liver parenchyma in patients with liver tumors before hepatic resection
Eligibility Criteria
Patients diagnosed with liver tumor intend to hepatectomy
You may qualify if:
- (i) patients with a solid focal liver lesion that was pathologically proven or diagnosed by imaging methods such as conventional US, CT or MR imaging; (ii) patients scheduled to undergo a hepatectomy; (iii) patients with a lesion ≥1.0 cm in diameter.
You may not qualify if:
- (i) patients with a history of chemotherapy; (ii) patients unable to properly hold their breath.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Huang Z, Zheng W, Zhang YJ, Xu L, Chen JB, Chen JC, Chen MS, Zhou Z. Assessing Hepatic Fibrosis Using 2-D Shear Wave Elastography in Patients with Liver Tumors: A Prospective Single-Center Study. Ultrasound Med Biol. 2017 Nov;43(11):2522-2529. doi: 10.1016/j.ultrasmedbio.2017.07.003. Epub 2017 Aug 12.
PMID: 28807448DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Minshan Chen
Sun Yat-sen University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor
Study Record Dates
First Submitted
November 5, 2016
First Posted
November 8, 2016
Study Start
June 1, 2015
Primary Completion
March 1, 2016
Study Completion
October 1, 2016
Last Updated
November 8, 2016
Record last verified: 2016-11
Data Sharing
- IPD Sharing
- Will not share